B

Bicara Therapeutics

Develops targeted therapies and tumor modulators

Associate Director - Global Scientific Communications

Biology & BiotechConfirmed live in the last 24 hours
Full-timeBoston, MA, USA$199k - $236k /yr

About the Job

Requirements

  • An advanced degree (PhD, PharmD, MD, or MSc) and at least 6 years of experience in Medical Affairs, Scientific Communications, or Publication Management are required.
  • A proven track record of directly managing the tactical planning, drafting, and execution of scientific publications in the biotech or pharmaceutical industry is required.
  • Expert knowledge and practical application of Good Publication Practices (GPP2022) and International Committee of Medical Journal Editors (ICMJE) guidelines are required.
  • The candidate must be able to interpret clinical trial data and simplify complex scientific concepts into clear, accurate medical messaging.
  • Hands-on experience managing external medical writing and scientific communication agencies, including timeline adherence and budget management, is required.
  • The candidate must be able to prioritize a high volume of deliverables in a fast-paced, deadline-driven environment.
  • The candidate must be able to influence and manage stakeholder input across a highly matrixed cross-functional team, such as Clinical, Biostatistics, Regulatory, and Legal.
  • Strong editorial and review capabilities, compliance awareness, and dedication to quality control are required.

Responsibilities

  • Lead the Publications Planning Team to develop the global publication plan, incorporating strategic input from Clinical Development, Research, Biostatistics, Regulatory, Legal, and Corporate Communications.
  • Oversee end-to-end development of manuscripts, abstracts, posters, oral presentations, and digital publication extenders for high-impact peer-reviewed journals and major scientific congresses.
  • Facilitate author and internal reviews, including the Medical-Legal-Regulatory (MLR) approval process, while ensuring compliance with GPP2022 and ICMJE guidelines.
  • Partner with and manage external scientific communication and medical writing agencies to ensure high-quality deliverables, timeline adherence, and budget optimization.
  • Ensure publications and medical deliverables align with the established Scientific Communication Platform (SCP), core lexicon, and broader Medical Affairs strategy.
  • Partner with internal teams to integrate established scientific narratives into ongoing Medical Affairs activities and maintain message consistency across global and regional outputs.
  • Monitor external literature and the competitive landscape to keep internal reference libraries and execution timelines aligned with the current asset landscape.
  • Assist in developing medical slide decks, FAQs, training materials, and interactive educational tools for field-based scientific exchange.
  • Support preparation of data-driven materials for medical advisory boards and scientific congresses.
  • Partner with Clinical Development and Medical Strategy to incorporate new clinical data into field-facing materials.
  • Ensure developed resources are scientifically accurate, fair-balanced, evidence-based, and compliant with internal and regulatory frameworks.

Desired Qualifications

  • Oncology or immuno-oncology experience is highly preferred.
  • ISMPP Certified Medical Publication Professional (CMPP) credential is highly desirable.
  • Proficiency with publication management software such as iEnvision/Datavision and PubsHub, and Medical-Legal-Regulatory review platforms such as Veeva PromoMats/MedComms, is preferred.
  • A strong scientific writing background and the ability to provide rigorous directional feedback to agency partners are preferred.

About the Company

Bicara Therapeutics

Develops targeted therapies and tumor modulators

Bicara Therapeutics develops cancer therapies that combine targeted precision treatment with tumor modulation to attack cancer cells and reshape the tumor environment. Its dual-action approach delivers agents to cancer cells with high specificity while adjusting surrounding tissue to boost anti-tumor activity. Unlike competitors that rely on a single strategy, Bicara aims to provide therapies that both kill cancer cells and modify the tumor site to improve patient outcomes. The company’s goal is to advance regulatory-approved therapies through research, trials, and partnerships with hospitals, cancer centers, and pharma companies to bring effective treatments to patients.

Company size
51-200
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2020

Recently Posted Jobs

Explore more opportunities at Bicara Therapeutics

See more jobs